Research Article
Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
Table 1
Demographic, clinical, and biochemical characteristics of type 1 diabetes individuals.
| | T1D participants () |
| | Clinical and biochemical characteristics | | | Age (year) | 34 (28–41) | | Sex, female (%) | 62 | | BMI (kg/m2) | 24.4 (22–27.5) | | eGFR (mL·min-1·1.73 m2) | 90 (70-110) | | Arterial hypertension (%) | 15 | | Total cholesterol (mg·dL-1) | 165 (147–185) | | (mmol·L-1) | 4.3 (3.8–4.8) | | Triglycerides (mg·dL-1) | 79 (56–103) | | (mmol·L-1) | 0.89 (0.63–1.16) | | Diabetes status | | | Diabetes duration (years) | 20 (15–27) | | Age at diagnosis (years) | 12 (7–18) | | HbA1C (%) | 8.2 (7.3–9.4) | | (mmol·mol-1) | 66 (56–79) | | Fructosamine (μmol·L-1) | 375 (321–450) | | Microvascular complications | | | Retinopathy (%) | 69.5 | | Diabetic kidney disease (%) | 29.7 | | Peripheral neuropathy (%) | 40.1 | | Cardiovascular autonomic neuropathy (%) | 46.7 | | Use of medicines | | | ACEI (%) | 28.2% | | Statin (%) | 38.9% |
|
|
Data are expressed as . BMI: body mass index; eGFR: estimated glomerular filtration rate; ACEI: angiotensin-converting enzyme inhibitors. |
